Basic Information
| LncRNA/CircRNA Name | LINC01096 |
| Synonyms | NA |
| Region | GRCh38_4:13546075-13547801 |
| Ensemble | ENSG00000246095 |
| Refseq | NR_015450 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Luciferase reporter assay |
| Sample | TNBC tissues and cells |
| Expression Pattern | up-regulated |
| Function Description | The expression of LINC01096 was enhanced in TNBC tissues and cells. |
| Pubmed ID | 31539132 |
| Year | 2019 |
| Title | LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p. |
External Links
| Links for LINC01096 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |